Welcome to Aura Pharm, where we blend nature’s purity with cutting-edge science to bring you Premium Precision in every Extract.
From cultivation to extraction, our commitment is to deliver wellness solutions crafted with precision and care.

The Market Opportunities
The European market is valued at €354M in 2022 and €516M in 2023, forecasted to grow to €2.1B by 2027 (CAGR 45%). Recent regulatory shifts in Europe, including EU rulings on CBD and UN recognition of cannabis’ medical value, support growing legalization. By 2026, global international sales are expected to reach $3.5B (CAGR 37%). Europe, home to 450M people and 25M cannabis users, is a key growth region.

Why Invest in Aura Pharm?
At Aura Pharm, we are redefining the future of the cannabis industry through innovation, sustainability, and a commitment to excellence. As a vertically integrated cannabis producer specializing in cultivation, extraction, and advanced genetic research, we are poised to lead the way in a rapidly expanding global market. Industry Growth Potential: The global cannabis market is forecasted to surpass $57 billion by 2030, offering unparalleled opportunities for strategic investments.
Setting a New Standard in Medical Cannabis Manufacturing
At Aura Pharm, we leverage advanced technology and rigorous methodologies to produce exceptional cannabis products that meet and exceed industry standards, aligning with the latest regulatory requirements.
Ensuring only best solutions for our clients
Recent articles


